Missouri HB 1524: Allows pharmaceutical companies to communicate off-label treatment uses to health care professionals

Status: Reported Do Pass (H) - AYES: 8 NOES: 0 PRESENT: 0 (as of 2018-04-26)

State: Missouri · Session: 2018 · Bill: HB 1524

Subjects: DRUGS AND CONTROLLED SUBSTANCES, HEALTH CARE PROFESSIONALS, PHARMACY

Sponsors: Neely, Jim

View Missouri HB 1524 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.